Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival.

Autor: Morales L; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA., Simpson D; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA., Ferguson R; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA., Cadley J; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA., Esteva E; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA., Monson K; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA., Chat V; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA., Martinez C; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA., Weber J; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA.; Department of Medicine, NYU Langone Health, New York, USA., Osman I; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA.; Department of Medicine, NYU Langone Health, New York, USA.; Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, USA., Kirchhof T; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA. Tomas.Kirchhof@nyulangone.org.; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA. Tomas.Kirchhof@nyulangone.org.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA. Tomas.Kirchhof@nyulangone.org.
Jazyk: angličtina
Zdroj: Journal of translational medicine [J Transl Med] 2023 Mar 31; Vol. 21 (1), pp. 234. Date of Electronic Publication: 2023 Mar 31.
DOI: 10.1186/s12967-023-04040-7
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje